Show
Sort by
-
- Journal Article
- A1
- open access
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4)
-
Guidance for the regulatory status of allergen extracts in clinical trials
-
The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
-
Cause-specific mortality in mild COPD : the Rotterdam study
-
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
-
The European Respiratory Society plans its future: the 2013-2018 strategic plan
-
Common genes underlying asthma and COPD? : genome-wide analysis on the Dutch hypothesis
-
Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD
-
Trustworthy guidelines on severe asthma thanks to ERS and ATS
-
Role of activin-A in cigarette smoke-induced inflammation and COPD